Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.

被引：1
|
作者：
Siegel, Abby B.
El-Khoueiry, Anthony B.
Finn, Richard S.
Guthrie, Katherine
Venook, Alan P.
Blanke, Charles David
Brown, Robert S.
机构：
[1] Columbia Univ, New York, NY USA
[2] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
401
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase II HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma.
    Grosu, Anca
    Gkika, Eleni
    Brunner, Thomas B.
    Thimme, Robert
    Weinberg, Uri
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [42] Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
    Weinmann, Arndt
    Niederle, Ina Maria
    Koch, Sandra
    Hoppe-Lotichius, Maria
    Heise, Michael
    Dueber, Christoph
    Schuchmann, Marcus
    Otto, Gerd
    Galle, Peter Robert
    Woerns, Marcus-Alexander
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (05) : 432 - 437
  • [43] Liver transplantation in a patient treated by sorafenib for hepatocellular carcinoma
    Borentain, P.
    Gregoire, E.
    Hardwigsen, J.
    Garcia, S.
    Durieux, O.
    Le Treut, Y. -P.
    Gerolami, R.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (03) : 234 - 236
  • [44] Phase II trial of sorafenib and capecitabine for hepatocellular carcinoma in cirrhotic patients
    Patt, Yehuda Z.
    Fekrazad, M. Houman
    Steinberg, Kim A.
    Bauman, Julie E.
    Lee, Sang-Joon
    Lee, Fa-Chyi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [45] Liver Transplantation Versus Liver Resection for the Treatment of Hepatocellular Carcinoma.
    Park, Min-Su
    Lee, Kwang-Woong
    Suh, Suk-Won
    You, Tae
    Kim, Hyeyoung
    Choi, YoungRok
    Hong, Geun
    Yi, Nam-Joon
    Suh, Kyung-Suk
    Kwon, Choon-Hyuck David
    Joe, Jae-Won
    Lee, Suk-Koo
    LIVER TRANSPLANTATION, 2013, 19 : S118 - S119
  • [46] Liver Transplantation Versus Liver Resection in the Treatment of Hepatocellular Carcinoma.
    Guo, Zhiyong
    Ju, Weiqiang
    Zheng, Zheng
    He, Xiaoshun
    LIVER TRANSPLANTATION, 2013, 19 : S277 - S277
  • [47] Efficacy of Sorafenib in Patients With Pulmonary Metastatic Hepatocellular Carcinoma after Liver Transplantation
    Chen, Yinghua
    Luo, Wenhui
    Ju, Weiqiang
    He, Xiaoshun
    Zhu, Xiaofeng
    LIVER TRANSPLANTATION, 2014, 20 : S256 - S256
  • [48] Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
    Shahda, Safi
    Loehrer, Patrick J.
    Clark, Romnee S.
    Spittler, A. John
    Althouse, Sandra K.
    Chiorean, E. Gabriella
    ONCOLOGIST, 2016, 21 (06): : 664 - 665
  • [49] A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma
    Yi, J.
    Ahn, H.
    Lee, S.
    Uhm, J.
    Lee, J.
    Park, S.
    Park, J.
    Park, Y.
    Lim, H.
    Kang, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Combination of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma: Results from a phase I extension trial
    Richly, H.
    Schultheis, B.
    Adamietz, I. A.
    Kupsch, P.
    Grubert, M.
    Hilger, R. A.
    Ludwig, M.
    Brendel, E.
    Christensen, O.
    Strumberg, D.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (04) : 579 - 587
12345